Clinical Trials Browser

Phase 1 × Carcinoma, Transitional Cell × sargramostim × Clear all

NCT00070070 2022-10-12

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Phase 1 Completed

6 enrolled 7 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell